Identifying common core outcome domains from core outcome sets of musculoskeletal conditions: protocol for a systematic review

Abstract

Background Core outcome sets (COSs) aim to reduce outcome heterogeneity in clinical practice and research by suggesting a minimum number of agreed-upon outcomes in clinical trials. Most COSs in the musculoskeletal field are developed for specific conditions. We propose that there are likely to be common core domains within existing musculoskeletal COSs that may be used as a starting point in the development of future COSs. We aim to identify common core domains from existing COSs and to facilitate the development of new COSs for musculoskeletal conditions. As a secondary aim, we will assess the development quality of these COSs. Methods A systematic review including musculoskeletal COSs. We will search Core Outcome Measures in Effectiveness Trials (COMET) database, MEDLINE, EMBASE, Scopus, Cochrane Methodology Register and International Consortium for Health Outcome Measurement (ICHOM). Studies will be included if related to the development of a COS in adults with musculoskeletal conditions and for any type of intervention. Quality will be assessed using the Core Outcome Set-Standards for Development (COS-STAD) recommendations. Data extracted will include scope of the COS, health condition, interventions and outcome domains. Primary outcomes will be all core domains recommended within each COS. We define a common core outcome domain as one present in at least 67% of all COSs. All findings will be summarized and presented using descriptive statistics. Discussion This systematic review of COSs will describe the core domains recommended within each musculoskeletal COS. Common domains found may be used in the initial stages of development of future musculoskeletal COSs. Systematic review registration PROSPERO CRD42021239141

Effectiveness of Telemedicine for Musculoskeletal Disorders: Umbrella Review

“…Currently, research is ongoing to identify common core outcome domains from core outcome sets of musculoskeletal conditions [85].…”

Validity of a smartphone app to objectively monitor performance outcomes in degenerative cervical myelopathy: an observational study

“…Whilst abnormal movement is a key component of diagnosis, it is also key a component of longitudinal monitoring, as these diseases typically lack responsive serological or imaging biomarkers. Such monitoring is key to adjust or review treatment strategies over time, and to define the success or failure of research trials (6). Today, monitoring relies on qualitative outcome measures: classifications based on a hierarchy of exemplar functions, such as questionnaires and/or item selection.…”